Literature DB >> 17569949

Long-term MR imaging course of neurodegenerative Langerhans cell histiocytosis.

H Prosch1, N Grois, M Wnorowski, M Steiner, D Prayer.   

Abstract

BACKGROUND AND
PURPOSE: MR imaging signal intensity abnormalities in the cerebellum, the pons, and the basal ganglia, compatible with a neurodegenerative process (ND) were reported in up to 10% of patients with Langerhans cell histiocytosis (LCH). Although the imaging features of ND-LCH have been extensively described, the temporal course of ND-LCH has not been assessed as of yet. The purpose of this study was to describe the long-term course of MR imaging signal intensity abnormalities in ND-LCH on T1- and T2-weighted images.
MATERIALS AND METHODS: In this retrospective study, 9 patients with ND-LCH with an observation time of at least 5 years were included. Three or more MR imaging studies per patient, performed in 3-year intervals (+/-11 months), were reviewed. Signal intensity abnormalities on T1- and T2-weighted images in the cerebellum, the pons, and basal ganglia were scored for their signal intensity quality and their extension. In addition, the severity of cerebellar atrophy was scored.
RESULTS: The signal intensity alterations were not resolved in any of the patients. Instead, a progression of the signal intensity alterations either in the cerebellum or basal ganglia was observed in all of the patients but did not correlate with a clinical deterioration. Overt and severe neurologic symptoms were reported in only 2 patients in whom some form of atrophy was noted.
CONCLUSIONS: ND-LCH appears to be a slowly progressive process. The increase of signal intensity abnormalities in the cerebellum and basal ganglia does not correlate with neurologic deterioration. MR imaging appears to be a sensitive technique to detect and monitor radiologic ND-LCH.

Entities:  

Mesh:

Year:  2007        PMID: 17569949      PMCID: PMC8134135          DOI: 10.3174/ajnr.A0509

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  30 in total

1.  Cerebellar degeneration in hereditary dentatorubral-pallidoluysian atrophy and Machado-Joseph disease.

Authors:  S Kumada; M Hayashi; M Mizuguchi; I Nakano; Y Morimatsu; M Oda
Journal:  Acta Neuropathol       Date:  2000-01       Impact factor: 17.088

2.  Central diabetes insipidus as presenting symptom of Langerhans cell histiocytosis.

Authors:  Helmut Prosch; Nicole Grois; Daniela Prayer; Franz Waldhauser; Manuel Steiner; Milen Minkov; Helmut Gadner
Journal:  Pediatr Blood Cancer       Date:  2004-10       Impact factor: 3.167

Review 3.  Central nervous system disease in Langerhans cell histiocytosis.

Authors:  N G Grois; B E Favara; G H Mostbeck; D Prayer
Journal:  Hematol Oncol Clin North Am       Date:  1998-04       Impact factor: 3.722

4.  Thickened pituitary stalk on MR images in patients with diabetes insipidus and Langerhans cell histiocytosis.

Authors:  R D Tien; T H Newton; M W McDermott; W P Dillon; J Kucharczyk
Journal:  AJNR Am J Neuroradiol       Date:  1990 Jul-Aug       Impact factor: 3.825

5.  Treatment strategy for disseminated Langerhans cell histiocytosis. DAL HX-83 Study Group.

Authors:  H Gadner; A Heitger; N Grois; I Gatterer-Menz; S Ladisch
Journal:  Med Pediatr Oncol       Date:  1994

6.  Central nervous system disease associated with Langerhans' cell histiocytosis.

Authors:  N Grois; A J Barkovich; W Rosenau; A R Ablin
Journal:  Am J Pediatr Hematol Oncol       Date:  1993-05

7.  MR imaging presentation of intracranial disease associated with Langerhans cell histiocytosis.

Authors:  Daniela Prayer; Nicole Grois; Helmut Prosch; Helmut Gadner; Anthony J Barkovich
Journal:  AJNR Am J Neuroradiol       Date:  2004-05       Impact factor: 3.825

8.  Central nervous system-related permanent consequences in patients with Langerhans cell histiocytosis.

Authors:  Edda Mittheisz; Rainer Seidl; Daniela Prayer; Marion Waldenmair; Birgit Neophytou; Ulrike Pötschger; Milen Minkov; Manuel Steiner; Helmut Prosch; Martha Wnorowski; Helmut Gadner; Nicole Grois
Journal:  Pediatr Blood Cancer       Date:  2007-01       Impact factor: 3.167

9.  Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society-Late Effects Study Group.

Authors:  Riccardo Haupt; Vasanta Nanduri; Maria Grazia Calevo; Cecilia Bernstrand; Jorge L Braier; Valerie Broadbent; Guadalupe Rey; Kenneth L McClain; Gritta Janka-Schaub; R Maarten Egeler
Journal:  Pediatr Blood Cancer       Date:  2004-05       Impact factor: 3.167

Review 10.  Demyelinating and gliotic cerebellar lesions in Langerhans cell histiocytosis.

Authors:  L B Poe; R L Dubowy; L Hochhauser; G H Collins; C J Crosley; M D Kanzer; M Oliphant; C J Hodge
Journal:  AJNR Am J Neuroradiol       Date:  1994-11       Impact factor: 3.825

View more
  13 in total

1.  MR spectroscopy of a bright cerebellar lesion in a patient with Langerhans cell histiocytosis.

Authors:  A Munoz; R Simon; G Carmen
Journal:  AJNR Am J Neuroradiol       Date:  2008-02-22       Impact factor: 3.825

Review 2.  Neuroimaging of Langerhans cell histiocytosis: a radiological review.

Authors:  Vikas Chaudhary; Shahina Bano; Rainy Aggarwal; Mahender Kaur Narula; Rama Anand; Ravi Shankar Solanki; Puran Singh
Journal:  Jpn J Radiol       Date:  2013-12       Impact factor: 2.374

3.  Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) patients.

Authors:  Alessandra Splendiani; Marco Perri; Claudia Marsecano; Valentina Vellucci; Giulia Michelini; Antonio Barile; Ernesto Di Cesare
Journal:  Radiol Med       Date:  2017-09-27       Impact factor: 3.469

4.  Erdheim-Chester disease presenting with chorea and mimicking IgG4-related disorder.

Authors:  Gadi Miron; Arnon Karni; Ahinoam Faust-Soher; Nir Giladi; Hilla Alroy; Avi Gadoth
Journal:  Neurol Clin Pract       Date:  2019-12

5.  T1 Signal Measurements in Pediatric Brain: Findings after Multiple Exposures to Gadobenate Dimeglumine for Imaging of Nonneurologic Disease.

Authors:  G K Schneider; J Stroeder; G Roditi; C Colosimo; P Armstrong; M Martucci; A Buecker; P Raczeck
Journal:  AJNR Am J Neuroradiol       Date:  2017-06-22       Impact factor: 3.825

6.  Waxing and Waning Neuroimaging Abnormalities in Langerhans Cell Histiocytosis.

Authors:  Luke V McCarron; Paul Kelly; Conal McConville; Peter Flynn; Mark O McCarron
Journal:  Neurol Clin Pract       Date:  2021-12

7.  Follow-up of pediatric patients treated by IVIG for Langerhans cell histiocytosis (LCH)-related neurodegenerative CNS disease.

Authors:  Shinsaku Imashuku; Naoto Fujita; Yoko Shioda; Haruyoshi Noma; Shiro Seto; Toshinori Minato; Kazuo Sakashita; Nobuhiro Ito; Ryoji Kobayashi; Akira Morimoto
Journal:  Int J Hematol       Date:  2014-12-10       Impact factor: 2.490

8.  Neurodegenerative central nervous system Langerhans cell histiocytosis and coincident hydrocephalus treated with vincristine/cytosine arabinoside.

Authors:  Carl E Allen; Ricardo Flores; Ronald Rauch; Robert Dauser; Jeffrey C Murray; Diane Puccetti; David A Hsu; Paul Sondel; Maxine Hetherington; Stan Goldman; Kenneth L McClain
Journal:  Pediatr Blood Cancer       Date:  2010-03       Impact factor: 3.167

9.  Magnetic resonance imaging differential diagnosis of brainstem lesions in children.

Authors:  Carlo Cosimo Quattrocchi; Yuri Errante; Maria Camilla Rossi Espagnet; Stefania Galassi; Sabino Walter Della Sala; Bruno Bernardi; Giuseppe Fariello; Daniela Longo
Journal:  World J Radiol       Date:  2016-01-28

10.  Histiocytosis-related cerebellar leukoencephalopathy.

Authors:  Bariş Ekici; Sevinç Gümüş; Meral Ozmen; Omer Devecioğlu
Journal:  J Pediatr Neurosci       Date:  2011-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.